Clinical Trial Update: Efficacy and Safety of Lymphdiaral Basistropfen (HDC) in the Treatment of Chronic Low-back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate the efficacy and safety of Lymphdiaral Basistropfen (HDC) for chronic low back pain. The study is completed and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Lymphdiaral Basistropfen (HDC)

Snippet

Sponsor: Pascoe Pharmazeutische Praeparate GmbH | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2012-09-06